Ibafloxacin

Ibafloxacin
Clinical data
Trade names	Ibaflin
AHFS/Drugs.com	International Drug Names
ATCvet code	QJ01MA96 (WHO) ;
Legal status
Legal status	CA: ℞-only; EU: Rx-only;
Identifiers
	IUPAC name 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acid;
CAS Number	91618-36-9 ;
PubChem CID	71186;
ChemSpider	64324 ;
UNII	53VPK9R0T5;
KEGG	D04485 ;
CompTox Dashboard (EPA)	DTXSID8057853 ;
Chemical and physical data
Formula	C15H14FNO3
Molar mass	275.279 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES Fc2cc1C(=O)/C(C(=O)O)=C\N3c1c(c2C)CCC3C;
	InChI InChI=1S/C15H14FNO3/c1-7-3-4-9-8(2)12(16)5-10-13(9)17(7)6-11(14(10)18)15(19)20/h5-7H,3-4H2,1-2H3,(H,19,20) ; Key:DXKRGNXUIRKXNR-UHFFFAOYSA-N ;
	(what is this?) (verify)

Ibafloxacin (INN) is a fluoroquinolone antibiotic^[1] drug formally approved for use in the European Union for veterinary medicine.^[2]

References

^ Horspool LJ, van Laar P, van den Bos R, Mawhinney I (June 2004). "Treatment of canine pyoderma with ibafloxacin and marbofloxacin--fluoroquinolones with different pharmacokinetic profiles". Journal of Veterinary Pharmacology and Therapeutics. 27 (3): 147–53. doi:10.1111/j.1365-2885.2004.00561.x. PMID 15189300.
^ "EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR) IBAFLIN" (PDF). European Medicines Agency. 1 September 2007.

This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it.